Finanzen von Huntsman Corp (HUN)HUNHuntsman Corp

Huntsman Corp (HUN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is MDI urethanes, accounting for 64.9% of total sales, equivalent to $1.08B. Other significant revenue streams include Speciality and Differentiated. Understanding this composition is critical for investors evaluating how HUN navigates market cycles within the Diversified Chemicals industry.

Evaluating the bottom line, Huntsman Corp maintains a gross margin of 14.73%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 1.44%, while the net margin is 0.54%. These profitability ratios, combined with a Return on Equity (ROE) of -6.14%, provide a clear picture of how effectively HUN converts its operational activities into shareholder value.

In the context of the broader market, HUN competes directly with industry leaders such as IOSP and NGVT. With a market capitalization of $1.43B, it holds a significant position in the sector. When comparing efficiency, HUN's gross margin of 14.73% stands against IOSP's 28.14% and NGVT's 44.64%. Such benchmarking helps identify whether Huntsman Corp is trading at a premium or discount relative to its financial performance.

Huntsman has shown fluctuating revenue with Q2 2026 revenue at $1.663 billion and a gross margin of 14.73%. However, net income remains negative, with Q2 2026 reporting a net income of $9 million, indicating ongoing challenges.